STAAR Surgical Company
STAA · NASDAQ
12/27/2024 | 12/29/2023 | 12/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $2 | $4 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $2 | $4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -2.6% | 13.4% | 23.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 76.3% | 78.4% | 78.5% | 77.5% |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -1.8% | 10.3% | 17% | 16% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -6.4% | 6.6% | 13.9% | 11.9% |
| EPS Diluted | -0.41 | 0.43 | 0.8 | 0.5 |
| % Growth | -195.3% | -46.3% | 60% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |